130 related articles for article (PubMed ID: 11038378)
21. An M2 Rather than a T
Lee DH; Ghiasi H
J Virol; 2018 May; 92(10):. PubMed ID: 29491152
[TBL] [Abstract][Full Text] [Related]
22. Construction and characterization of a glycoprotein E gene-deleted bovine herpesvirus type 1 recombinant.
Chowdhury SI; Ross CS; Lee BJ; Hall V; Chu HJ
Am J Vet Res; 1999 Feb; 60(2):227-32. PubMed ID: 10048557
[TBL] [Abstract][Full Text] [Related]
23. Rise and survival of bovine herpesvirus 1 recombinants after primary infection and reactivation from latency.
Schynts F; Meurens F; Detry B; Vanderplasschen A; Thiry E
J Virol; 2003 Dec; 77(23):12535-42. PubMed ID: 14610176
[TBL] [Abstract][Full Text] [Related]
24. An in vivo study of a glycoprotein gIII-negative bovine herpesvirus 1 (BHV-1) mutant expressing beta-galactosidase: evaluation of the role of gIII in virus infectivity and its use as a vector for mucosal immunization.
Liang X; Babiuk LA; Zamb TJ
Virology; 1992 Aug; 189(2):629-39. PubMed ID: 1322592
[TBL] [Abstract][Full Text] [Related]
25. Two Separate Tyrosine-Based YXXL/Φ Motifs within the Glycoprotein E Cytoplasmic Tail of Bovine Herpesvirus 1 Contribute in Virus Anterograde Neuronal Transport.
Yezid H; Lay CT; Pannhorst K; Chowdhury SI
Viruses; 2020 Sep; 12(9):. PubMed ID: 32937797
[TBL] [Abstract][Full Text] [Related]
26. Identification of a novel protein encoded by the latency-related gene of bovine herpesvirus 1.
Meyer F; Perez S; Jiang Y; Zhou Y; Henderson G; Jones C
J Neurovirol; 2007 Dec; 13(6):569-78. PubMed ID: 18097888
[TBL] [Abstract][Full Text] [Related]
27. Neurovirulence of glycoprotein C(gC)-deleted bovine herpesvirus type-5 (BHV-5) and BHV-5 expressing BHV-1 gC in a rabbit seizure model.
Chowdhury SI; Lee BJ; Onderci M; Weiss ML; Mosier D
J Neurovirol; 2000 Aug; 6(4):284-95. PubMed ID: 10951552
[TBL] [Abstract][Full Text] [Related]
28. Latency and reactivation of a glycoprotein E negative bovine herpesvirus type 1 vaccine: influence of virus load and effect of specific maternal antibodies.
Lemaire M; Schynts F; Meyer G; Georgin JP; Baranowski E; Gabriel A; Ros C; Belák S; Thiry E
Vaccine; 2001 Sep; 19(32):4795-804. PubMed ID: 11535332
[TBL] [Abstract][Full Text] [Related]
29. Rapid detection of bovine herpesvirus 1 in the semen of infected bulls by a nested polymerase chain reaction assay.
Masri SA; Olson W; Nguyen PT; Prins S; Deregt D
Can J Vet Res; 1996 Apr; 60(2):100-7. PubMed ID: 8785714
[TBL] [Abstract][Full Text] [Related]
30. Role of interferon-gamma in inducing cytotoxicity of peripheral blood mononuclear leukocytes to bovine herpesvirus type 1 (BHV-1)-infected cells.
Campos M; Ohmann HB; Hutchings D; Rapin N; Babiuk LA; Lawman MJ
Cell Immunol; 1989 Apr; 120(1):259-69. PubMed ID: 2539268
[TBL] [Abstract][Full Text] [Related]
31. The effect of bovine herpesvirus type 1 glycoproteins gI and gIII on herpesvirus infections.
Chase CC; Carter-Allen K; Letchworth GJ
J Gen Virol; 1989 Jun; 70 ( Pt 6)():1561-9. PubMed ID: 2543789
[TBL] [Abstract][Full Text] [Related]
32. Vaccination with a gE-negative bovine herpesvirus type 1 vaccine confers insufficient protection to a bovine herpesvirus type 5 challenge.
Silva AD; Spilki FR; Franco AC; Esteves PA; Hübner SO; Driemeier D; Oliveira AP; Rijsewijk F; Roehe PM
Vaccine; 2006 Apr; 24(16):3313-20. PubMed ID: 16480790
[TBL] [Abstract][Full Text] [Related]
33. A quantitative study of the efficacy of a deletion mutant bovine herpesvirus-1 differential vaccine in reducing the establishment of latency by wildtype virus.
Galeota JA; Flores EF; Kit S; Kit M; Osorio FA
Vaccine; 1997 Feb; 15(2):123-8. PubMed ID: 9066027
[TBL] [Abstract][Full Text] [Related]
34. Comparison of pathological changes and viral antigen distribution in tissues of calves with and without preexisting bovine viral diarrhea virus infection following challenge with bovine herpesvirus-1.
Risalde MA; Molina V; Sónchez-Cordón PJ; Pedrera M; Romero-Palomo F; Bautista MJ; Moreno A; Gómez-Villamandos JC
Am J Vet Res; 2013 Apr; 74(4):598-610. PubMed ID: 23531068
[TBL] [Abstract][Full Text] [Related]
35. A study on latency in calves by five vaccines against bovine herpesvirus-1 infection.
Castrucci G; Frigeri F; Salvatori D; Ferrari M; Dico ML; Rotola A; Sardonini Q; Petrini S; Cassai E
Comp Immunol Microbiol Infect Dis; 2002 Jul; 25(4):205-15. PubMed ID: 12135235
[TBL] [Abstract][Full Text] [Related]
36. Recombinant virus-expressed bovine cytokines do not improve efficacy of a bovine herpesvirus 1 marker vaccine strain.
König P; Beer M; Makoschey B; Teifke JP; Polster U; Giesow K; Keil GM
Vaccine; 2003 Dec; 22(2):202-12. PubMed ID: 14615147
[TBL] [Abstract][Full Text] [Related]
37. Experimental infection of calves with a gI, gE, US9 negative bovine herpesvirus type 5.
Hübner SO; Oliveira AP; Franco AC; Esteves PA; Silva AD; Spilki FR; Rijsewijk FA; Roehe PM
Comp Immunol Microbiol Infect Dis; 2005 May; 28(3):187-96. PubMed ID: 15857658
[TBL] [Abstract][Full Text] [Related]
38. Amended recombinant cells (ARCs) expressing bovine IFN-gamma: an economical and highly effective adjuvant system.
Gaertner FH; Babiuk LA; Mutwiri G; Armstrong JM; Griebel PJ
Vaccine; 2009 Feb; 27(9):1377-85. PubMed ID: 19150640
[TBL] [Abstract][Full Text] [Related]
39. Primary infection, latency, and reactivation of bovine herpesvirus type 5 in the bovine nervous system.
Perez SE; Bretschneider G; Leunda MR; Osorio EA; Flores EF; Odeón AC
Vet Pathol; 2002 Jul; 39(4):437-44. PubMed ID: 12126146
[TBL] [Abstract][Full Text] [Related]
40. Establishment of latency associated with glycoprotein E (gE) seroconversion after bovine herpesvirus 1 infection in calves with high levels of passive antibodies lacking gE antibodies.
Schynts F; Lemaire M; Ros C; Belak S; Thiry E
Vet Microbiol; 2001 Sep; 82(3):211-22. PubMed ID: 11470543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
